Subscribe to Newsletter

Digital Technologies

Manufacture Advanced Medicine

The Next Decade of Cell and Gene Therapies

| 5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems; we ask experts about the future of advanced medicine.

Business & Regulation Digital Technologies

AI, Big Data, and Digital Disruption

| Rob Ellison | 7 min read

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.

Business & Regulation Digital Technologies

Forecasting Medicine Use and Controlling Supply Chains

| Tim Tinnel | 3 min read

The role of digital technologies in optimizing traceability in pharmaceutical supply chains.

Manufacture Advanced Medicine

Partnership Cuts Cost of CAR T Manufacturing

| 4 min read

Manufacturing bottlenecks remain a key hurdle in CAR-T therapy. Can automation and digital integration change that?

Discovery & Development Clinical Trials

The Role of Data in Drug Development

| Daniel Chancellor | 4 min read

How connecting the data dots can lead to better development and clinical trals. 

Discovery & Development Contract Development Services

The Lab of the Future: Combining Automation with Digital Tools

| Dean Mulyk | 6 min read

Manufacture Advanced Medicine

Integrating Technology and Robotics in CGT Manufacturing

| 7 min read

How the right partnerships are helping streamline CGT manufacturing through robotics and digital tools.

Manufacture Advanced Medicine

Digital Twins in CAR-T Manufacturing

| Marc-Olivier Baradez | 4 min read

Here’s why the Cell and Gene Therapy Catapult is excited about the potential of digital twin technology.

Discovery & Development Clinical Trials

AI in Oncology: The Bridge Between the Patient and the Practice

| 2 min read

Using AI to improve oncology care and find the right clinical trials for patients.

Business & Regulation Digital Technologies

The Three Pillars of AI

| 4 min read

AI helps make preclinical decisions faster, but stakeholders remain cautious. We asked an expert from Elsevier for their views on the challenges.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register